- Home
- BLBX vs APRE Comparison
BLBX vs APRE Comparison
Compare BLBX & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLBX
- APRE
- Stock Information
- Founded
- BLBX 2014
- APRE 2006
- Country
- BLBX United States
- APRE United States
- Employees
- BLBX N/A
- APRE N/A
- Industry
- BLBX EDP Services
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLBX Technology
- APRE Health Care
- Exchange
- BLBX Nasdaq
- APRE Nasdaq
- Market Cap
- BLBX 10.6M
- APRE 9.7M
- IPO Year
- BLBX N/A
- APRE 2019
- Fundamental
- Price
- BLBX $3.88
- APRE $1.81
- Analyst Decision
- BLBX
- APRE Strong Buy
- Analyst Count
- BLBX 0
- APRE 2
- Target Price
- BLBX N/A
- APRE $15.50
- AVG Volume (30 Days)
- BLBX 36.1K
- APRE 32.1K
- Earning Date
- BLBX 05-15-2025
- APRE 05-14-2025
- Dividend Yield
- BLBX N/A
- APRE N/A
- EPS Growth
- BLBX N/A
- APRE N/A
- EPS
- BLBX N/A
- APRE N/A
- Revenue
- BLBX $2,504,604.00
- APRE $1,284,475.00
- Revenue This Year
- BLBX N/A
- APRE N/A
- Revenue Next Year
- BLBX N/A
- APRE N/A
- P/E Ratio
- BLBX N/A
- APRE N/A
- Revenue Growth
- BLBX N/A
- APRE 33.27
- 52 Week Low
- BLBX $1.51
- APRE $1.41
- 52 Week High
- BLBX $6.00
- APRE $5.01
- Technical
- Relative Strength Index (RSI)
- BLBX 61.25
- APRE 54.62
- Support Level
- BLBX $3.73
- APRE $1.60
- Resistance Level
- BLBX $4.07
- APRE $1.97
- Average True Range (ATR)
- BLBX 0.21
- APRE 0.18
- MACD
- BLBX 0.03
- APRE 0.02
- Stochastic Oscillator
- BLBX 74.32
- APRE 65.00
About BLBX Blackboxstocks Inc.
Blackboxstocks Inc is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Its web-based software (the Blackbox System) employs predictive technology enhanced by artificial intelligence to find volatility and unusual market activity that may result in a rapid change in the price of a stock or option. It provides users with a fully interactive social media platform that is integrated into its dashboard, enabling users to exchange information and ideas quickly and efficiently through a common network. The company introduced a live audio/video feature that allows members to broadcast on their channels to share trading strategies and market insight within the Blackbox community.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.